Market Scenario

There are various symptoms of arteriovenous malformation which include bleeding in the skull, most commonly a subarachnoid hemorrhage, headaches, focal neurologic deficits such as weakness, numbness, or tingling in one part or side of the body, muscle weakness, inability to move a limb, and lack of coordination. It is estimated that 15 % patients with AVM may have difficulty with movement, speech and vision.

According to the American Stroke Association, AVMs are more common in males than in females, more than 50% of patients with an AVM have intracranial hemorrhage and amongst AVM patients, 20%-25% have focal or generalized seizures.

According to the World Health Organization estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5092

According to the American Stroke Association, AVMs are more common in males than in females, more than 50% of patients with an AVM have intracranial hemorrhage and amongst AVM patients, 20%-25% have focal or generalized seizures.

Increasing prevalence of brain diseases/disorders, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases will fuel the market growth during the forecast period. Moreover, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies. However, limited availability of facilities and higher treatment cost may hinder the market growth during the forecast period.

The global arteriovenous malformation market is expected to grow at a CAGR of ~6.1% during the forecast period 2017-2023.

Key Players

Toshiba Medical Systems Corporation (Japan)
Carestream Health (U.S.)
Nihon Kohden Corporation (Japan)
Electrical Geodesics Inc. (U.S.)
Fujifilm Holdings (Japan)
GE Healthcare (U.S.)
Siemens Healthcare(U.S.)
Philips Healthcare (U.S.)
Shimadzu Corporation (Japan)
Masimo Corporation (U.S.)
Hologic (U.S.)
Esaote (Italy)
Segmentations

The global arteriovenous malformation market is segmented on the basis of types, diagnosis, treatment, and end user.

On the basis of diagnosis it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), and electroencephalography (EEG).

On the basis of treatment it is segmented into endovascular embolization, neurosurgery and others.

On the basis of types it is segmented into true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and dural fistula.

On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/arteriovenous-malformation-market-5092

Table Of Content

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5 Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

...Continued!




About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]